Rahlfs, biometrician, second appraisal commissioned by Regumed GmbH. Reviews further clinical and laboratory studies of the BICOM method submitted by the manufacturer and assigns each a level of evidence. Commissioned by the device maker, which is stated here so you can weigh it.
Category Archives: Manufacturer commissioned
Funded, commissioned or published by a device manufacturer or its institute. Reported here as it was published; the commercial interest is stated so you can take it into account.
Rahlfs and Rozehnal, first biometric appraisal commissioned by Regumed GmbH. Describes each submitted BICOM study, its design and its results, and rates its level of evidence on the American Heart Association scale. Commissioned by the device maker.
Twenty two slides from Regumed summarising the Rahlfs appraisal: the level of evidence scheme, and the allergy, asthma, liver cell, overstrain and allergy testing studies with the grade each was given. Manufacturer material, presented as such.
10
May
May
IGEF and IIREC reports on the Regumed Protector, a device sold for protection against electromagnetic fields from Wi-Fi, mobile phones and DECT handsets. Biophysical testing submitted by the manufacturer. Not a bioresonance therapy study.
Papcz and Barovic, translated and adapted by Rome and Moyses for Regumed. Two groups of top athletes with overstrain syndrome, one treated conventionally and one with BICOM resonance therapy, compared on pain rating, treatment period and number of sessions. Reports a difference favouring the BICOM group.
A prospective randomised study, translated from the German, of patients with slight liver cell damage: one group treated with endogenous electromagnetic fields through a BICOM device, one control, with liver enzymes (GOT, GPT, gamma GT) compared. Published in the Regumed compendium.
Hans Brügemann, head of the Institute for Regulative Medicine, Gräfelfing. A congress talk on what level of evidence means and which BICOM studies reach which level, drawing on the Rahlfs appraisal. The manufacturer’s own account of its evidence base.
An overview of the nine studies the Institute for Regulative Medicine published as Wissenschaftliche Studien zur BICOM Resonanz-Therapie: the Schumacher allergy series, the Chinese asthma and skin series, the liver cell trial, the sportsmen study and others, with each result as the Institute reported it.